Showing 1 - 9 results of 9 for search 'Levine, R', query time: 0.68s
Refine Results
-
1
POTENTIAL-ENERGY SURFACE EFFECTS ON DIFFERENTIAL CROSS-SECTIONS FOR POLYATOMIC REACTIONS by Nyman, G, Clary, D, Levine, R
Published 1995Journal article -
2
PERIPHERAL CHEMICAL-REACTIONS by Bennun, M, Brouard, M, Simons, J, Levine, R
Published 1993Journal article -
3
From Rydberg state dynamics to ion-molecule reactions using ZEKE spectroscopy by Softley, T, Mackenzie, S, Merkt, F, Rolland, D, Neumark, D, Levine, R, Kohler, B, Child, MS
Published 1997Conference item -
4
Supersuppression: Reservoir competency and timing of mosquito host shifts combine to reduce spillover of West Nile Virus. by Levine, R, Mead, D, Hamer, G, Brosi, B, Hedeen, D, Hedeen, M, McMillan, J, Bisanzio, D, Kitron, U
Published 2016Journal article -
5
General discussion on molecular Rydberg states and ZEKE spectroscopy .2. by Levine, R, Jungen, C, Miller, W, Cederbaum, L, Hess, B, Softley, T, Field, R, Kohler, B, Child, MS, Jain, SR, Lombardi, M
Published 1997Conference item -
6
General discussion on intramolecular dynamics by Letokhov, V, Quack, M, Marcus, R, Woste, L, Troe, J, Pollak, E, Levine, R, Fleming, G, Manz, J, Neusser, H, Softley, T, Kobayashi, T
Published 1997Conference item -
7
General discussion on molecular Rydberg states and ZEKE spectroscopy .1. by Casati, G, Lorquet, J, Schlag, E, Levine, R, Gauyacq, D, Schinke, R, Jungen, C, Shapiro, M, Zewail, A, Neumark, D, Engel, V, Manz, J, Woste, L, Child, MS, Even, U, Herman, M, Letokhov, V, Softley, T, Chergui, M
Published 1997Conference item -
8
Clonal heterogeneity in differentiation response and resistance to the IDH2 inhibitor enasidenib in acute myeloid leukemia by Quek, L, David, M, Kennedy, A, Metzner, M, Amatangelo, M, Shih, A, Stoilova, B, Karamitros, D, Quivoron, C, Heiblig, M, Willekens, C, Saada, V, Peniket, A, Bernard, O, Agresta, S, Yen, K, Stein, E, De Botton, S, Thakurta, A, Levine, R, Penard-Lacronique, V, Vyas, P
Published 2017Conference item -
9
Clonal heterogeneity of acute Myeloid Leukemia treated with the IDH2 inhibitor Enasidenib by Vyas, P, Quek, L, David, MD, Kennedy, A, Metzner, M, Amatangelo, M, Shih, A, Stoilova, B, Quivoron, C, Heiblig, M, Willekens, C, Saada, V, Alsafadi, S, Vijayabaskar, MS, Peniket, A, Bernard, OA, Agresta, S, Yen, K, MacBeth, K, Stein, E, Vassiliou, GS, Levine, R, De Botton, S, Thakurta, A, Penard-Lacronique, V
Published 2018Journal article